NCT06954584 2025-06-24Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian CancerTongji HospitalPhase 3 Recruiting424 enrolled
NCT01482286 2022-03-15PULSEPennington Biomedical Research CenterPhase 3 Terminated32 enrolled 10 charts